Pro zobrazení tohoto obsahu je třeba být přihlášen.
Author Archives for m.popovic@wemakemedia.cz
Diagnostika a liečba hypopituitárneho nanizmu u nových pacientov v detskom veku
7 októbra, 2020 6:31 pm Leave your thoughtsVýchodisko Na diagnózu hypopituitárneho nanizmu – deficitu rastového hormónu (GHD) – myslíme obvykle vtedy, ak je aktuálna výška − 2...
Vážené kolegyne, vážení kolegovia,
7 októbra, 2020 6:31 pm Leave your thoughtsprihováram sa vám v období, keď verím, že už máme za sebou tie najnáročnejšie týždne, ktoré sme prežili s napätím v pracovnom aj...
Five-year overall survival (OS) update from a phase II, open-label trial of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600–mutant unresectable or metastatic melanoma (MM)
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Melanoma/ Skin cancers Abstract number: 9505 Citation: J Clin Oncol 35,...
COMBI-MB: A phase II study of combination dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600–mutant (mut) melanoma brain metastases (MBM)
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Melanoma/ Skin cancers Abstract number: 9506 Citation: J Clin Oncol 35,...
Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Melanoma/ Skin cancers Abstract number: 9504 Citation: J Clin Oncol 35,...
A randomized phase II study of nivolumab or nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases (mets): The Anti-PD1 Brain Collaboration (ABC)
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Melanoma/Skin Cancers Abstract number: 9508 Citation: J Clin Oncol 35, 2017...
Efficacy and safety of nivolumab (NIVO) plus ipilimumab (IPI) in patients with melanoma (MEL) metastatic to the brain: Results of the phase II study CheckMate 204
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Melanoma/Skin Cancers Abstract number: 9507 Citation: J Clin Oncol 35, 2017...
Combined Checkpoint Inhibition Ushers in a New Era of CNS Therapy in Melanoma
29 septembra, 2020 8:31 pm Leave your thoughtsJune 4, 2017 Data from two phase II studies, the CheckMate 204 trial and the Anti-PD1 Brain Collaboration (ABC)...
KONGRES ASCO 2017 PRINIESOL ŠTYRI HLAVNÉ KLINICKY KRITICKÉ SPRÁVY V LIEČBE MALÍGNEHO MELANÓMU
29 septembra, 2020 8:31 pm Leave your thoughts1. Boli publikované dlhodobé výsledky trojročného celkového prežívania pacientov v rámci štúdie Keynote-006. Predbežné výsledky štúdie Keynote-006, ktorá porovnávala ipilimumab (blokátor...
Phase II study of maintenance pembrolizumab (pembro) in extensive stage small cell lung cancer (ES-SCLC) patients (pts)
29 septembra, 2020 8:31 pm Leave your thoughtsMeeting: 2017 ASCO Annual Meeting Track: Lung Cancer – Non-small Cell Local-Regional/Small Cell/Other Thoracic Cancer Abstract number: 8504...